5 Oct 2021

WHO Along With Independent Group Of Experts Scheduled To Meet Next Week

Latest reports have been coming in from the world Health organisation which has stated that WHO along with an independent group of experts are scheduled to meet next week.

This group will meet next week to carry out the risk and benefit assessment and come to a final decision whether to grant Emergency Use Listing to Covaxin according to World Health Organization.

Covaxin manufacturer, Bharat Biotech, has been submitting data to WHO on a rolling basis and submitted additional info at WHO’s request on Sept 27. 

WHO experts are currently reviewing this information and if it addresses all questions raised, WHO assessment will be finalized next week.

The Emergency Use Listing process done by WHO and the Technical Advisory Group of independent experts is centred on determining if a manufactured product (eg a vaccine) is quality-assured, safe and effective according to World Health Organization.

No comments:

Post a Comment